FCM
CHNG

Freshford Capital Management’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Freshford Capital Management’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-237,182
Closed -$6.52M – 26
2022
Q3 		$6.52M Sell
237,182
-1,901,818
-89% -$47.1M 1.01% 21
2022
Q2 		$49.3M Buy
2,139,000
+18,145
+0.9% +$424K 6.74% 6
2022
Q1 		$46.2M Buy
2,120,855
+200,677
+10% +$4.17M 6.29% 8
2021
Q4 		$41.1M Buy
1,920,178
+447,256
+30% +$9.38M 5.64% 6
2021
Q3 		$30.8M Buy
1,472,922
+302,415
+26% +$6.6M 4.4% 12
2021
Q2 		$27M Hold
1,170,507
– – 3.66% 13
2021
Q1 		$25.9M Sell
1,170,507
-1,081,356
-48% -$25M 3.6% 12
2020
Q4 		$42M Buy
2,251,863
+1,064,113
+90% +$17.5M 6.1% 6
2020
Q3 		$17.2M Buy
+1,187,750
New +$15.1M 2.98% 12

Other funds holding CHNG

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Freshford Capital Management's CHNG Position: Q4 2022 in Review

Freshford Capital Management sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 237,182 shares — an estimated $6.52M sold.

Freshford Capital Management first reported a position in CHNG in Q3 2020 and held it in 9 quarters. The position peaked at $49.3M in Q2 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Freshford Capital Management reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Freshford Capital Management sold 237,182 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $6.52M.
  • Freshford Capital Management first reported a position in Change Healthcare Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Freshford Capital Management's Change Healthcare Inc. Common Stock position peaked at $49.3M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Freshford Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.